Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Financial Results:
Alkem Laboratories Ltd reported Revenues for Q2FY25 of ₹3,415.00 Crores down from ₹3,440.00 Crore year on year, a fall of 0.73%.
Total Expenses for Q2FY25 of ₹2,769.00 Crores down from ₹2,797.00 Crores year on year, a fall of 1.0%.
Consolidated Net Profit of ₹702.00 Crores up 14.15% from ₹615.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹57.60, up 10.98% from ₹51.90 in the same quarter of the previous year.